Morgan Stanley upgrades Moelis stock rating on record deal pipeline

Published 23/06/2025, 06:24
Morgan Stanley upgrades Moelis stock rating on record deal pipeline

Investing.com - Morgan Stanley (NYSE:MS) upgraded Moelis (NYSE:MC) from Underweight to Overweight on Monday, raising its price target to $68.00 from $42.00. The investment bank currently trades at a P/E ratio of 23.42 and offers a 4.6% dividend yield, having maintained dividend payments for 12 consecutive years. According to InvestingPro analysis, the company shows good overall financial health with strong cash flow metrics.

The upgrade follows optimistic comments from Moelis at Morgan Stanley’s US Financials Conference, where the investment bank reported its deal pipeline is at record levels and has increased since April. The firm indicated that while interest rate cuts would be beneficial, they are not necessary for the pipeline to convert to completed deals. This confidence is supported by the company’s impressive 45.14% revenue growth over the last twelve months and strong liquidity position, with a current ratio of 2.19.

Morgan Stanley projects Moelis’ compensation ratio will improve from 69% in the first quarter of 2025 to 63% in 2026, driven by higher revenues. This improvement in the compensation ratio combined with revenue growth is expected to drive a 74% increase in 2026 earnings per share compared to 2025, and a 91% increase versus 2024. Discover more detailed financial projections and 8 additional key insights with InvestingPro’s comprehensive research report.

The investment bank’s expansion into Private Funds Advisory (PFA) is anticipated to drive significant revenue growth over time. Moelis recently hired Matt Wesley from Jefferies to lead this initiative, with plans to both reallocate internal talent and focus external hiring on building this division.

Moelis will initially concentrate on continuation funds within its PFA business, with plans to expand into other capabilities including dividend recapitalizations, limited partner stake sales, and fundraising, citing long-term structural demand for continuation funds as a major opportunity.

In other recent news, Moelis & Company reported its first-quarter 2025 results, with adjusted diluted earnings per share of $0.64, slightly below Citizens JMP’s estimate of $0.65 but above the consensus estimate of $0.59. The company’s revenues reached $307 million, marking an approximately 41% increase compared to the same quarter last year, with two-thirds of the revenue coming from mergers and acquisitions. Citizens JMP analysts maintained a Market Perform rating on Moelis, citing elevated non-compensation expenses and market uncertainty despite the revenue growth. Meanwhile, Keefe, Bruyette & Woods reaffirmed their Outperform rating for Moelis, maintaining a price target of $69, following the announcement of a leadership transition. Ken Moelis, the current CEO, will step down to become Executive Chairman, with Navid Mahmoodzadegan, the firm’s Co-President and co-founder, succeeding him as CEO. This leadership change, effective October 1, 2025, is part of a long-term transition plan. Analysts express confidence in Mahmoodzadegan’s extensive experience and strategic role within the company. The company remains optimistic about its future under the new leadership.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.